Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
- 1 June 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 5 (3) , 347-363
- https://doi.org/10.1586/14760584.5.3.347
Abstract
Neutralizing antibody induction is a key feature of many effective vaccines and is the only immune response that has proven to be capable of completely blocking AIDS virus infection in animal models. Unfortunately, the extensive genetic variability and complex immune-evasion strategies of HIV-1 have thwarted all attempts to date at eliciting an effective neutralizing antibody response with candidate HIV-1 vaccine immunogens. Recent advances in our understanding of how these evasion strategies operate, coupled with growing progress in unravelling the structure and immunobiology of the viral envelope glycoproteins, are contributing to novel immunogen designs to overcome the many barriers to inducing protective antibodies against HIV-1.Keywords
This publication has 144 references indexed in Scilit:
- High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human SubjectsThe Journal of Infectious Diseases, 2005
- Comparison of HIV Type 1 ADA gp120 Monomers versus gp140 Trimers as Immunogens for the Induction of Neutralizing AntibodiesAIDS Research and Human Retroviruses, 2005
- Complete Protection of Neonatal Rhesus Macaques against Oral Exposure to Pathogenic Simian‐Human Immunodeficiency Virus by Human Anti‐HIV Monoclonal AntibodiesThe Journal of Infectious Diseases, 2004
- Induction of Neutralizing Antibodies and Gag-Specific Cellular Immune Responses to an R5 Primary Isolate of Human Immunodeficiency Virus Type 1 in Rhesus MacaquesJournal of Virology, 2001
- Relationships between CD4 Independence, Neutralization Sensitivity, and Exposure of a CD4-Induced Epitope in a Human Immunodeficiency Virus Type 1 Envelope ProteinJournal of Virology, 2001
- QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humansPublished by Elsevier ,2001
- CDR Walking Mutagenesis for the Affinity Maturation of a Potent Human Anti-HIV-1 Antibody into the Picomolar RangeJournal of Molecular Biology, 1995
- Neutralization of HIV-1AIDS Research and Human Retroviruses, 1994
- Synergistic Neutralization of HIV-1 by Human Monoclonal Antibodies Against the V3 Loop and the CD4-Binding Site of gp120AIDS Research and Human Retroviruses, 1992
- Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency VirusScience, 1988